Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Apricus expands Vitaros agreement with Ferring, terminates agreement with Sandoz

July 27, 2016

Resverlogix begins dosing in phase I study of apabetalone in severe renal impairment

July 22, 2016

FDA accepts Revive's IND for a phase II trial of bucillamine for cystinuria

July 7, 2016

Pfizer introduces AMPK activators

June 22, 2016

FDA approves Rayaldee for secondary hyperparathyroidism in CKD

June 21, 2016

Boehringer Ingelheim discloses aldosterone synthase inhibitors

June 20, 2016

Astellas Pharma and Kotobuki Pharmaceutical patent leucyl-cystinyl aminopeptidase antagonists

June 17, 2016

Eli Lilly and Company develops PKC inhibitors

June 3, 2016

FDA issues complete response letter for sodium zirconium cyclosilicate for hyperkalemia

May 27, 2016

Linaclotide shows preclinical potential for bladder hyperactivity

May 25, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 27, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...